SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2104)1/14/2008 9:52:46 AM
From: Jibacoa  Read Replies (2) | Respond to of 3722
 
ANX Is up 7.29% on volume now >100Ks

bigcharts.marketwatch.com

It announced safety results for ANX-530, which has demonstrated a statistically significant reduction in injection site reactions when compared to Navelbine (p<0.05).

ANX-530 was determined to be safe and well-tolerated with no significant differences observed in any other safety parameters.

ANX intends to submit to the FDA an NDA for ANX-530 in the 4thQ.

Bernard